ArticleBreast cancer research : BCR2022

Steroid receptor coactivator-3 inhibition generates breast cancer antitumor immune microenvironment.

Sang Jun Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.